+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 20Years - 90Years
All Genders
ID04880265

Studying How Common and Impactful Atrial Fibrillation Is After Heart Surgery Using Wearable EKG Sensors

Led by Brigham and Women's Hospital · Updated on 2026-06-30

150

Participants Needed

1

Research Sites

147 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying atrial fibrillation AF, a common complication occurring in 30 to 60% of patients after cardiac surgery. This research aims to better understand the prevalence and risk factors of AF in patients undergoing elective open heart surgery. The study is observational and seeks to improve risk prediction models by collecting detailed data on patients who experience AF postoperatively. Participants will wear a Vivalink wearable life sensor device that continuously collects electrocardiogram EKG data to monitor heart rhythms. This device is used after cardiac surgery to gather accurate information on AF occurrences. The study observes patients during the hospital stay and up to 30 days after discharge to capture arrhythmia events. During the study, participants heart rhythms are closely monitored through the wearable device, and researchers collect epidemiological data to analyze risk factors. The main outcome measured is the presence of atrial fibrillation within 30 days after hospital discharge, with other arrhythmias also recorded. The study spans several years, allowing for comprehensive data collection and analysis of postoperative AF burden and related complications.

CONDITIONS

Brief Title

Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Research Team

J

Jakob Wollborn, MD MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here